The drugmaker will pay $10 million in the case, plus additional contributions worth $10.4 million, to avoid going to trial in two Ohio counties for its role in the opioids crisis.
from NYT > Top Stories https://ift.tt/2pcA7DD
https://ift.tt/eA8V8J
No comments:
Post a Comment